×
Close
註冊
登入
主页
用户
博客
照片
视频
医学图书S馆
医学图书M馆
医学图书D馆
医学术语
群组
活动
用户工具
用户指南
问答
谁看过我
反馈
语言
English
中文
推广
所有
MeSH descriptor
Mesh Subheading
Mesh Supplementary Concept
Mesh Pharmacological Action
search
搜索
清除所有
MeSH 搜索器
AND
OR
加入MeSH搜索引擎
搜索PubMed论文列
清除所有
Benzodiazepinones
推出的年份: 1974
副标题
administration and dosage
adverse effects
agonists
analysis
antagonists and inhibitors
blood
cerebrospinal fluid
chemical synthesis
chemistry
classification
economics
history
immunology
isolation and purification
metabolism
pharmacokinetics
pharmacology
poisoning
radiation effects
standards
supply and distribution
therapeutic use
toxicity
urine
树号:
D03.633.100.079.080.070
MeSH 单一 ID:
D001570
All MeSH Categories
Chemicals and Drugs Category
Heterocyclic Compounds [D03]
Heterocyclic Compounds, Fused-Ring [D03.633]
Heterocyclic Compounds, 2-Ring [D03.633.100]
Benzazepines [D03.633.100.079]
Benzodiazepines [D03.633.100.079.080]
Alprazolam [D03.633.100.079.080.030]
Benzodiazepinones [D03.633.100.079.080.070]
Anthramycin [D03.633.100.079.080.070.050]
Bromazepam [D03.633.100.079.080.070.110]
Clonazepam [D03.633.100.079.080.070.150]
Devazepide [D03.633.100.079.080.070.200]
Diazepam [D03.633.100.079.080.070.216]
add_circle
Flumazenil [D03.633.100.079.080.070.305]
Flunitrazepam [D03.633.100.079.080.070.320]
Flurazepam [D03.633.100.079.080.070.348]
Lorazepam [D03.633.100.079.080.070.450]
Nitrazepam [D03.633.100.079.080.070.565]
Oxazepam [D03.633.100.079.080.070.663]
Pirenzepine [D03.633.100.079.080.070.750]
Prazepam [D03.633.100.079.080.070.784]
Temazepam [D03.633.100.079.080.070.880]
Chlordiazepoxide [D03.633.100.079.080.150]
Clobazam [D03.633.100.079.080.165]
Clorazepate Dipotassium [D03.633.100.079.080.180]
Estazolam [D03.633.100.079.080.250]
Medazepam [D03.633.100.079.080.550]
Midazolam [D03.633.100.079.080.575]
Olanzapine [D03.633.100.079.080.738]
Triazolam [D03.633.100.079.080.900]
thumb_up
Like
share
分享
favorite
书签
0
0
0
0
0
0
0
留言 (
0
)
gif
登入或註冊以發表你的留言
Modal title
×
Modal title
×
分享
登入
Global News and Health Forum
Join Now!
馬上登入
記住我
忘記密碼?
或者使用
Linkedin
留言 (0)